Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Genomenon has raised $5.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Genomenon's investors include University of Michigan, National Institutes of Health, Spring Mountain Capital, Beringea, Michigan Rise.
Genomenon is headquartered in Ann Arbor, United States.
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Genomenon is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genomenon — Funding & Investors." VCBacked, May 16, 2024, https://www.vcbacked.co/company/genomenon. Accessed July 19, 2026.
VCBacked. (2024). Genomenon — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/genomenon
{{cite web |title=Genomenon — Funding & Investors |url=https://www.vcbacked.co/company/genomenon |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated